Dexcom Inc (DXCM) Stock: Thought Concerns
RBC Capital Mkts raised the price target for the Dexcom Inc (NASDAQ:DXCM) stock to “an Outperform”. The rating was released on March 12, 2024, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $138. The stock was initiated by UBS, […]
Are Options A Good Investment Right Now? Dexcom Inc (DXCM) Stock
RBC Capital Mkts raised the price target for the Dexcom Inc (NASDAQ:DXCM) stock to “an Outperform”. The rating was released on March 12, 2024, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $138. The stock was initiated by UBS, […]
RBC Capital Mkts Sets Dexcom Inc (NASDAQ:DXCM) Stock to “an Outperform”
RBC Capital Mkts raised the price target for the Dexcom Inc (NASDAQ:DXCM) stock to “an Outperform”. The rating was released on March 12, 2024, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $138. The stock was initiated by UBS, […]
Dexcom Inc (NASDAQ:DXCM) Stock is trading at a margin of 2.34% From 20-Day SMA
RBC Capital Mkts raised the price target for the Dexcom Inc (NASDAQ:DXCM) stock to “an Outperform”. The rating was released on March 12, 2024, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $138. The stock was initiated by UBS, […]
Dexcom Inc (DXCM) Stock: Pessimism is a stepping stone to opportunity
RBC Capital Mkts raised the price target for the Dexcom Inc (NASDAQ:DXCM) stock to “an Outperform”. The rating was released on March 12, 2024, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $138. The stock was initiated by UBS, […]
initiated: RBC Capital Mkts Recommends Dexcom Inc (NASDAQ:DXCM) Stock to “an Outperform”
RBC Capital Mkts raised the price target for the Dexcom Inc (NASDAQ:DXCM) stock to “an Outperform”. The rating was released on March 12, 2024, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $138. The stock was initiated by UBS, […]
